[Epstein-barr virus gene expression in latent infection and B-lymphocyte growth transformation].
Harada
Shizuko
S
Department of Virology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan. shizuko@nih.go.jp
D001402:B-Lymphocytes / Q000821:virology*; D002472:Cell Transformation, Viral; D020031:Epstein-Barr Virus Infections / Q000235:genetics / Q000821:virology*; D019309:Epstein-Barr Virus Nuclear Antigens / Q000502:physiology; D015967:Gene Expression Regulation, Viral; D004854:Herpesvirus 4, Human / Q000235:genetics*; D006801:Humans; D014763:Viral Matrix Proteins / Q000502:physiology; D014764:Viral Proteins / Q000502:physiology; D017735:Virus Latency / Q000235:genetics*
C402641:EBNA-2 protein, Human herpesvirus 4; C402640:EBNA-LP protein, Human herpesvirus 4; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D019309:Epstein-Barr Virus Nuclear Antigens; D014763:Viral Matrix Proteins; D014764:Viral Proteins; C417029:EBV-encoded nuclear antigen 1